section name header

Pronunciation

fex-oh-FEN-a-deen

Classifications

Therapeutic Classification: allergy, cold and cough remedies

Pharmacologic Classification: antihistamines

Indications

REMS


Action

  • Antagonizes the effects of histamine at peripheral histamine–1 (H1) receptors, including pruritus and urticaria.
  • Also has a drying effect on the nasal mucosa.
Therapeutic effects:
  • Decreased sneezing, rhinorrhea, itchy eyes, nose, and throat associated with seasonal allergies.
  • Decreased urticaria.

Pharmacokinetics

Absorption: Rapidly absorbed after oral administration.

Distribution: Unknown.

Metabolism/Excretion: 80% excreted in urine, 11% excreted in feces.

Half-Life: 14.4 hr ( in renal impairment).

Time/Action Profile

(antihistaminic effect)

ROUTEONSETPEAKDURATION
POwithin 1 hr2–3 hr12–24 hr



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

GI: dyspepsia

GU: dysmenorrhea

Neuro: drowsiness, fatigue

Interactions

Drug-drug:

Route/Dosage

Renal Impairment

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Allegra, Allegra Allergy, Children's Allegra Allergy, Children's Allegra Hives, Mucinex Allergy

Pill Image

fexofenadine_135-990.jpg

Code

NDC Code